Vaxcyte Inc.

12/03/2024 | Press release | Distributed by Public on 12/03/2024 07:00

Vaxcyte Initiates Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants